Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Kitasato Institute and Tella to collaborate on dendritic cell vaccine study

Oct. 8, 2013

MorphoSys completes phase I/IIa study of MOR-208 in CLL

Oct. 7, 2013

European submission to broaden label for Arzerra to include first-line CLL

Oct. 7, 2013

Heat Biologics files IND for HS-410 in bladder cancer

Oct. 3, 2013

Scancell provides update on its drug discovery pipeline

Oct. 3, 2013

Phase I/II trial of Mologen's renal cancer vaccine meets primary endpoints

Oct. 2, 2013

FDA grants accelerated approval of new indication for Perjeta

Oct. 2, 2013

MEDI-4736 treatment results in significant tumor suppression

Oct. 2, 2013

New French biotechnology company formed to develop MAb for ovarian cancer

Oct. 2, 2013

Results of phase III trial demonstrate improvements in PFS and PSA responses with ipilimumab

Oct. 1, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...